Eldad J Dann

11PUBLICATIONS
24CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseasesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursAnimal production not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 14, 2026
Real-world outcomes of BrECADD therapy in advanced-stage classical Hodgkin lymphoma: A multicentre retrospective study.

|Feb 13, 2026
Platelet and Fibrinogen Dynamics After CAR-T Cell Therapy in Relapsed/Refractory B-Cell Lymphoma May Predict ICANS Onset.

Hazim Khatib, Amit Parizat, Jabour Halloun

|Sep 15, 2025
Duration of anti-CD20 monoclonal antibody maintenance positively correlates with clinical outcomes in follicular lymphoma patients, supporting adherence to the recommended 2-year maintenance paradigm.

Michal Nordkin, Nashwa Fadaos, Ronit Leiba

|Dec 17, 2024
In COVID-19 Patients Supported with Extracorporeal Membrane Oxygenation, Intensive Care Unit Mortality Is Associated with the Blood Transfusion Rate.

Maged Makhoul, Eldad J Dann, Tatiana Mashiach

|Jun 19, 2024
Treatment Strategies in Advanced-Stage Hodgkin Lymphoma.

Eldad J Dann, René-Olivier Casasnovas

|Nov 14, 2023
The impact of CHOP versus bendamustine on bone mineral density in patients with indolent lymphoma enrolled in the GALLIUM study.

Mette Abildgaard Pedersen, Lars C Gormsen, Lasse H Jakobsen

Pageof 2

Frequent Collaborators

2 joint publications

Shimrit Ringelstein-Harlev

2 joint publications

Tsila Zuckerman

1 joint publications

Mette Abildgaard Pedersen

1 joint publications

Lars C Gormsen